logo
Infosys, TCS, Wipro: Will top IT companies gain momentum in Q1FY26?

Infosys, TCS, Wipro: Will top IT companies gain momentum in Q1FY26?

India Today09-07-2025
India's top IT companies are stepping into Q1FY26 with little room for celebration. Despite what's typically a strong seasonal quarter, the outlook is tepid.Equirus Securities, in its earnings preview, signals a subdued performance for the sector, where even the heavyweights are struggling to regain momentum. 'Soft quarter' is the verdict across the board. Growth is likely to be muted. Deal flow isn't picking up pace. And cautious client behaviour—especially in manufacturing and hi-tech—continues to stall decision-making.advertisementTCS, Infosys, and Wipro may not have much to flaunt this quarter.
Equirus expects constant currency (CC) revenue growth for the top six IT firms to range between -2.6% and +1.4%, a narrow band that barely moves the needle. Even the engineering services players, often seen as growth engines, are expected to shrink by 3–3.6% QoQ.Infosys might offer a slight reprieve. It's likely to post 1.4% CC growth, with some help from inorganic deals. But even here, margins are expected to dip by 10 bps thanks to wage hikes and normalised expenses. The company could tweak its FY26 guidance slightly upward—from 0–3% to 1.0–3.25%—but that's hardly a showstopper.Wipro's performance could be softer still. Revenues may shrink by 2.6% in CC terms, and the company may guide for another flat-to-negative quarter ahead. Meanwhile, TCS is bracing for a modest 0.4% dip, weighed down by the ramp-down of the BSNL deal and weak traction overseas.WHAT ABOUT MIDCAP IT FIRMS?While the large caps are treading water, some mid-tier players could offer a glimmer of hope. Coforge, Persistent, Zensar, eClerx, and Mphasis are expected to post QoQ growth between 1.3% and 7% in dollar terms. Coforge, in particular, is projected to lead the midcap pack.Equirus remains bullish on Infosys and Tech Mahindra among the big names, while Zensar, KPIT, eClerx, and Mphasis stand out in the midcap universe. But overall, the firm advises investors to stay selective—valuations have already run up, and the earnings momentum just isn't keeping pace.LOWER CLIENT DEMANDAcross the sector, demand remains cautious. Clients—especially in the U.S.—are still hesitating, with delays in project ramp-ups and muted order flows. The one exception may be BFSI, which continues to offer some tailwinds. But even here, optimism is tempered by uncertainty around global trade and tariff decisions.The real story this quarter will be told in the commentary. How are clients thinking about tech budgets for FY26? Are mega deals moving forward? Are pricing pressures easing? These questions may matter more than the numbers themselves.WHAT TO WATCH?Infosys: Expect modest growth, but no fireworks. Guidance may inch up slightly, but margins could be under pressure. Project Maximus and the absence of visa costs offer some cushion, but not enough to turn the tide.advertisementTCS: Revenue is likely to dip slightly. Deferred wage hikes may help margins, but the bigger worry is soft demand and a slowdown in large deal closures.Wipro: Still in recovery mode. The Marelli bankruptcy may cloud the outlook further, and the street will be watching for clues on deal flow and growth strategy.HCL Tech: Seasonal softness is expected to drag down services revenue. Margins could compress by 77 bps. No change expected in its full-year guidance.Tech Mahindra: Revenue might dip slightly, but cost optimisation (under Project Fortius) and currency gains could lift margins. Investors will look for clues on the telecom business and 5G pipeline.The bottom line: India's IT giants are still in wait-and-watch mode. There are pockets of stability—and a few outperformers—but the sector's broader recovery remains sluggish. For now, the real story isn't in the Q1 numbers. It's in the tone of management commentary and whether it signals a real turnaround or just more of the same.- Ends
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Grok Imagine goes viral; over 20 million images generated in 24 hours
Grok Imagine goes viral; over 20 million images generated in 24 hours

Economic Times

timean hour ago

  • Economic Times

Grok Imagine goes viral; over 20 million images generated in 24 hours

Agencies The new text-to-video generation application Grok Imagine, led by artificial intelligence (AI) company xAI, has witnessed a surge, with over 20 million images generated as of Tuesday, chief executive Elon Musk posted on X (formerly Twitter).A day before, over 14 million images were generated. Earlier on Tuesday, Musk announced that the Grok Imagine app is available to all X Premium users. Additionally, the app is accessible for both iOS and Android a series of tweets, Musk reposted creatives by users experimenting with the app, which is currently in an early beta phase. From recreating historical events to making posters and even animated memes, Imagine has taken over the internet. Valentine is the latest animated, voice-enabled AI companion introduced by xAI's Grok platform. He joins earlier companions like Ani, a goth anime-style avatar, and Rudy, the sarcastic red panda, as part of Grok's character-driven user took to X, describing how Grok Imagine brought the fondest memories to have praised the production quality and Grok's ability to go extravagant when it comes to creativity. Access to Grok Imagine According to Musk, users can update their X app and request access to the waitlist by navigating to the 'Grok' section in settings and selecting 'Imagine.' Grok Imagine allows users to generate videos of up to six minutes duration and still images from text prompts. In addition, it can animate static images into moving visuals with synchronised sound, offering creators a more seamless workflow without needing external tools or software. The feature is available both via the standalone Grok app and within the main X platform. According to a post by the official Grok handle, full public rollout is expected in phases beginning October 2025. Elevate your knowledge and leadership skills at a cost cheaper than your daily tea. Can Coforge's ambition to lead the IT Industry become a reality? BlackRock returns, this time with Ambani. Will it be lucky second time? Amazon is making stealthy moves in healthcare, here's why! The trader who blew the whistle on Jane Street Stock Radar: Globus Spirits breaks out from 9-month consolidation; check target & stop loss for long positions Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports Plus These large-caps have 'strong buy' & 'buy' recos and an upside potential of more than 25% Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 36% in 1 year

Cement, steel, infrastructure and pharma companies will continue to do well: Pashupati Advani
Cement, steel, infrastructure and pharma companies will continue to do well: Pashupati Advani

Economic Times

time12 hours ago

  • Economic Times

Cement, steel, infrastructure and pharma companies will continue to do well: Pashupati Advani

Live Events You Might Also Like: Take it one day at a time; not very bullish or very bearish at this point in time: Mihir Vora (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel , Founder & Chairman,, says the Indian government will continue economic stimulus through infrastructure and real estate spending. Cement, steel, and infrastructure companies are expected to benefit. Indian pharmaceutical companies are doing well, especially with relaxed US regulations. The ban on small packet imports into the US could indirectly benefit Indian pharma. Generics will allow Indian pharma to we have had companies that have good earnings trying to come out earlier and the ones with indifferent earnings came out in the latter half of the month. This time it has been the reverse, where the worst ones have come out first and the better ones have come towards the end of the month and that has given a little bit of a push to the markets and that has made everybody reality is that a lot of this is temporary because we are really in a position to be able to absorb a 25% tariff hike into the US. People just have to look into which companies are benefiting and which companies are going to get hurt. and in those and then try to figure out which ones are going to do well and which ones are not going to do my side, I feel that IT stocks should be under pressure. Unfortunately or fortunately, today they are the active winners, with TCS and Infosys up there in the top part of the gainers, but that is temporary because the model is having to be changed and I do not know whether these two can actually lead the others and make the model change so that people will be able to benefit. This has got nothing to do with the markets, but has to do with the way AI is coming and the way Microsoft and Google and open AI are changing the world. It is here to reality is that the government is continuing to spend to stimulate the economy. They are going to continue in infrastructure, real estate, and roads. So, those companies that benefit from that are going to be in the space and will be the ones to pharmaceutical companies are doing okay. We seem to have gotten some reprieve from the US because a lot of the pharmaceuticals are considered to be essential, and so they have not been on the tariff list or are at a much lower tariff and that is good for of the things that people have not noticed so much is that the US used to have a ban on small packets that used to be sent by post into the US and a lot of pharmaceuticals were coming as second sale from Canada and from Mexico into the US. That has now stopped and that is going to have some effect but it is not really going to be meaningful because our pharmaceuticals can go straight in.I am very bullish still on cement, steel, and to some extent on infra companies and even though big pharma in the US is getting attacked by the US president, I would consider our pharma companies to be small pharma, and we should be able to slip in and as generics, we are able to do well. These sectors are definitely going to be interesting for us in India.

Cement, steel, infrastructure and pharma companies will continue to do well: Pashupati Advani
Cement, steel, infrastructure and pharma companies will continue to do well: Pashupati Advani

Time of India

time13 hours ago

  • Time of India

Cement, steel, infrastructure and pharma companies will continue to do well: Pashupati Advani

Pashupati Advani , Founder & Chairman, Global Foray , says the Indian government will continue economic stimulus through infrastructure and real estate spending. Cement, steel, and infrastructure companies are expected to benefit. Indian pharmaceutical companies are doing well, especially with relaxed US regulations. The ban on small packet imports into the US could indirectly benefit Indian pharma. Generics will allow Indian pharma to thrive. What are you making of the market right now in terms of how the earnings have shaped up so far? The first half of the earning season was not that good but in the last three or four sessions, we have seen good moves coming in. Pashupati Advani: Traditionally we have had companies that have good earnings trying to come out earlier and the ones with indifferent earnings came out in the latter half of the month. This time it has been the reverse, where the worst ones have come out first and the better ones have come towards the end of the month and that has given a little bit of a push to the markets and that has made everybody happy. Productivity Tool Zero to Hero in Microsoft Excel: Complete Excel guide By Metla Sudha Sekhar View Program Finance Introduction to Technical Analysis & Candlestick Theory By Dinesh Nagpal View Program Finance Financial Literacy i e Lets Crack the Billionaire Code By CA Rahul Gupta View Program Digital Marketing Digital Marketing Masterclass by Neil Patel By Neil Patel View Program Finance Technical Analysis Demystified- A Complete Guide to Trading By Kunal Patel View Program Productivity Tool Excel Essentials to Expert: Your Complete Guide By Study at home View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program The reality is that a lot of this is temporary because we are really in a position to be able to absorb a 25% tariff hike into the US. People just have to look into which companies are benefiting and which companies are going to get hurt. and in those and then try to figure out which ones are going to do well and which ones are not going to do well. On my side, I feel that IT stocks should be under pressure. Unfortunately or fortunately, today they are the active winners, with TCS and Infosys up there in the top part of the gainers, but that is temporary because the model is having to be changed and I do not know whether these two can actually lead the others and make the model change so that people will be able to benefit. This has got nothing to do with the markets, but has to do with the way AI is coming and the way Microsoft and Google and open AI are changing the world. It is here to stay. In this market, select underperformers are also holding up, a case in point being autos and staple companies. In the near term, the news flows regarding the market share gain, the earnings are boding well. Do you trust this move for a good runup from these levels, from an investor point of view or should one really bet on these themes right now? Pashupati Advani: The reality is that the government is continuing to spend to stimulate the economy. They are going to continue in infrastructure, real estate, and roads. So, those companies that benefit from that are going to be in the space and will be the ones to buy. Live Events You Might Also Like: Take it one day at a time; not very bullish or very bearish at this point in time: Mihir Vora Again, pharmaceutical companies are doing okay. We seem to have gotten some reprieve from the US because a lot of the pharmaceuticals are considered to be essential, and so they have not been on the tariff list or are at a much lower tariff and that is good for us. One of the things that people have not noticed so much is that the US used to have a ban on small packets that used to be sent by post into the US and a lot of pharmaceuticals were coming as second sale from Canada and from Mexico into the US. That has now stopped and that is going to have some effect but it is not really going to be meaningful because our pharmaceuticals can go straight in. I am very bullish still on cement, steel, and to some extent on infra companies and even though big pharma in the US is getting attacked by the US president, I would consider our pharma companies to be small pharma, and we should be able to slip in and as generics, we are able to do well. These sectors are definitely going to be interesting for us in India.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store